Information
Name of lifestyle Smoke
Third Class NA
Second Class Smoke
First Class Habits+behaviors
Unit packs/year
Stratification 18444148:Never ;Former ;Current
27975054:Nonsmokers;Former;Current
18211697:Current smoker;Non-smoker
23929133:Never ;Past;0-20 ;20-40 ;≥40
25971353:Positive versus negative
11065004:Never;Ex-smokers;Current smokers
12869398:Nonsmoker;Former smoker;Current smoker
10861465:Never smokers;Past smokers;<20 cigarette/day ;≥20 cigarette/day;0.25-19 ;20-39;≥40;0.25,19 ;20,39
10755415:Never;Former;Current
9087923:Smoker;Nonsmoker;Smoker vs.nonsmoker
18704722:Never;Former;Current
15010890:Never;Current;Former
11484949:Nerer(Reference group);Ex-smoker;Current smoke;Ever-smoked
26243447:Never;Former: <10 cigarettes/d;Former: 10-19 cigarettes/d;Former: ≥20 cigarettes/d;Current: <10 cigarettes/d;Current: 10-19 cigarettes/d 0.86(0.77-0.95);Current: ≥20 cigarettes/d
24083722:Never;Past;Current
23169298:Never smokers;Former smoker;Current smoker
24515125:Never;Former;Current
25139338:Never Smokers ;Former smoke ;Current Smokers
25884961:Never;Former;Current
27535659:Never;Ever
23656798:Yes;No
28332895:NA
28910820:Never;Former;Current
25256860:No;Yes
Type of influence factor Protective factor
Risk factor
No statistical significance factor
Classification of Lifestyles Habits+behaviors
The affected types of PCa Total PCa
Local PCa
Advanced PCa
Total PCa(detected by subjective symptoms);
Local PCa(detected by subjective symptoms)
Advanced PCa(detected by subjective symptoms);
Non Fatal PCa
Fatal PCa
Moderate grade PCa
High grade PCa
Low grade PCa
Incident PCa
High risk PCa
Number of studies involved 24
24 Items, 2 Pages <<Prev 1 2 Next>> All
Research involved
PMID First auther Year Area Duration Study type Sample size More
18444148 Gholamreza Pourmand 2008 Iran November 2005, December 2006 Case-Control 62;68 baseline
outcome
27975054 Somia Lass 2016 Algeria 2011, 2013 case-control 90;190 baseline
outcome
18211697 Laura Q Rogers 2008 United States of America cross-sectional 2524;61138 baseline
outcome
23929133 Norie Sawada 2014 Japan 1990, 1993 11240;4372;10575;9892;12139;11319;11566;25333 baseline
outcome
25971353 Yishuo Wu 2015 China (Shanghai) July 2012, December 2013 46;54 baseline
outcome
11065004 Josep M.Ramon 2000 Spain (Barcelona metropolitan area) May 1994, March 1998 case-control 217;434 baseline
outcome
12869398 Lora A. Plaskon 2003 United States of America (Washington State) 1993, 1996 casecontrol 753;703 baseline
outcome
10861465 Paulo A. LOTUFO 2000 10909;8667;850;1559 baseline
outcome
10755415 TI Lund Nilsen 2000 Norway (Nord-Trøndelag) 1984, 1986 22895 outcome
9087923 Marcus Stanaland 2017 United States of America 2001, 2010 cross ,sectional 11547 baseline
outcome
18704722 Lindsay Mag 2008 United States of America (Fargo,ND) 2004, 2006 hospital-based case–control 312;319 outcome
15010890 YANCUI 2004 1988, 1994 case-control 95;8720 outcome
11484949 G. G. Giles 2001 Melbourne,Sydney and Perth 1994, 1998 case-control 1476;1409 outcome
26243447 Song-Yi Park 2015 United States of America (Hawaii and California) 1993, 1996 Cohort 75216 outcome
24083722 Jong-Myon Bae 2013 Seoul 1993, 2008 cohort study 14450 outcome
23169298 S Rohrmann 2013 France,Germany, UK,Greece,Italy, ,The Netherlands ,Norway,Spain ,Sweden 1992, 2009 cohort study 145112 baseline
outcome
24515125 TI Lund Nilsen 2000 Norway 1984, 1986 questionnaires 22895 outcome
25139338 Tammy Ho 2014 multicenter, randomized, double-blind, placebo-con 2937;2554;929 baseline
outcome
25884961 Kirsten T Eriksen 2015 Denmark December 1993, May 1997 questionnaire 1567;26778 baseline
outcome
27535659 Trond Heir 2016 Norway (Oslo) 1972, 2012 1997 outcome